The Growth and Decline of Q4 2022 and Q1 2023 Holdings: What Changed with Ironwood Financial, LLC?

Ironwood Financial, LLC is a well-known hedge fund company that manages assets worth over $3.2 billion. As with all hedge funds, Ironwood Financial LLC has to report its quarterly holdings to SEC through the 13F filing. The 13F filing contains a detailed report of all stocks, ETFs, and other securities the hedge fund company purchased or sold in the last quarter. In this article, we will delve into the comparison between the Q4 2022 vs. Q1 2023 13F holdings of Ironwood Financial LLC.

The table above shows us the key changes that took place in the holdings of Ironwood Financial, LLC over the last quarter. From a cursory glance, the data shows us that Ironwood Financial, LLC made significant investments in the technology sector, specifically Apple and Microsoft. These two stocks combined for a total value of over $42,000,000. However, the company also sold some of its shares in Pfizer, which resulted in a loss of approximately $375,000.

When we compare the Q4 2022 position of Ironwood Financial, LLC with its Q1 2023 position, one of the notable changes we see involves the ISHARES TR. According to the data, Ironwood Financial LLC increased its holdings in this security by 2.89%, which translated to an additional 2,846 shares. Also, the company increased its holdings in INVESCO EXCH TRD SLF IDX FD by 18.5% during the same period. This increase translated to an additional 156,846 shares and suggests that Ironwood Financial, LLC sees potential in the fund.

Another interesting observation is the company's shift towards exchange-traded funds (ETFs) from mutual funds. In the Q4 2022 position, Ironwood Financial, LLC invested in the iShares TR, which is an ETF, and two mutual funds: the Vanguard Index FDS and the Vanguard Tax-Managed FDS. However, in the Q1 2023 position, the company only invested in ETFs, showing a clear shift towards the former.

One position that Ironwood Financial, LLC decreased its holdings in the Q1 2023 position is Pfizer. This change is a result of the company selling 375 shares, which translated to a decrease of 2.04%. The other decrease in holding was in iShares TR, where the company sold 782 shares, a 5.81% decrease in holdings from the Q4 2022 position.

In conclusion, even though the Q4 2022 and Q1 2023 13F holdings of Ironwood Financial LLC show a mixed bag of results, it's notable that the company has increased several of its holdings,  particularly in the technology sector. Ironwood Financial, LLC's diversification in investment strategies, specifically towards ETFs, suggests that the company is willing to explore and invest in other assets. While there is always a level of risk involved, the company believes that these investments will generate positive returns for their clients in the long run.